Dr. Fleming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Nicole Fleming is a Gynecologic Oncologist in Houston, TX and is affiliated with the University of Texas M.D. Anderson Cancer Center. She received her medical degree from McGovern Medical School at UTHealth and has been in practice 13 years. She specializes in gynecologic oncology and is experienced in general obstetrics and gynecology, gynecologic oncology, and minimally invasive gynecologic surgery. She has more than 70 publications and over 500 citings. She has held administrative positions as Center Medical Director at MD Anderson Sugar Land campus, Inpatient Medical Director for Gynecology services at MD Anderson hospital, and Director of Surgery in the MD Anderson Cancer Network.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gynecologic Oncology, 2008 - 2011
- Duke University HospitalResidency, Obstetrics and Gynecology, 2004 - 2008
- McGovern Medical School at UTHealthClass of 2004
Certifications & Licensure
- CA State Medical License 2008 - Present
- FL State Medical License 2021 - Present
- TN State Medical License 2023 - 2026
- GA State Medical License 2023 - 2025
- TX State Medical License 2011 - 2025
- AL State Medical License 2023 - 2024
- WA State Medical License 2023 - 2024
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2016 Feb 04
Roles: Principal Investigator, Contact
- Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer Start of enrollment: 2015 Sep 23
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study.Madeline T Olson, Brian Madajewski, Brian Ostrander, Kartik Krishnan, Patrick Wagner, Edward A Levine, Alex C Kim, Perry Shen, Nicole D Fleming, Shannon N Westin, Laur...> ;Annals of Surgical Oncology. 2024 Apr 15
- Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer ...Knisely, A., Iniesta, M., Batman, S., Cain, K., Marten, C., Chisholm, G., Meyer, L., Soliman, P., Schmeler, K., Taylor, J., Fleming, N.> ;Gynecologic Oncology. 2024 Feb 16
- 1 citationsRandomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.Emily M Hinchcliff, Anne Knisely, Naomi Adjei, Bryan Fellman, Ying Yuan, Ami Patel, Cai Xu, Shannon N Westin, Anil K Sood, Pamela T Soliman, Aaron Shafer, Nicole D Fle...> ;Cancer. 2024 Apr 1
- Join now to see all
Journal Articles
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerShannon N Westin, Lois M Ramondetta, Kathleen M Schmeler, Pamela T Soliman, Nicole D Fleming, Jennifer K Burzawa, Alpa M Nick, Andrea M Milbourne, Diane C Bodurka, Rob..., American Journal of Obstetrics and Gynecology
Lectures
- Correlation of surgeon radiology assessment with laparoscopic scoring in patients with advanced-stage ovarian cancer.2019 ASCO Annual Meeting - 6/1/2019
- An Oncology Symposium For The Primary Care ProviderThe University of Texas, M. D. Anderson Cancer Center, Sugar Land, Texas - 9/29/2012
- 5th Symposium on Emerging Treatments & Advances in Novel Cancer Therapies for Practicing Physicians & Healthcare ProfessionalsCancerNet, LLC, Dallas, Texas - 1/18/2012
Authored Content
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
Professional Memberships
- Member
- Member
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
- Memorial Hermann Sugar Land HospitalSugar Land, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: